Evidence map›Paper›PMID 34472582›Full record

ArticleBiology open2021

A versatile, automated and high-throughput drug screening platform for zebrafish embryos.

Alexandra Lubin, Jason Otterstrom, Yvette Hoade, Ivana Bjedov, Eleanor Stead, Matthew Whelan, Gaia Gestri, Yael Paran, Elspeth Payne

Registry-linked trialAbstract read
In one paragraph

Article in Biology open, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05289076 (Protocol for Evaluation of Oncological Treatment in Patients With CRLM Using Zebra Fish Avatars-may This Model Improve Resection Rates and Survival in Patients With Upfront Non-resectable Metastatic Disease?), which is not on this map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05289076 phase1 / phase2unknown statusnot on this mapstarted 2022, after this paper: background citation

Protocol for Evaluation of Oncological Treatment in Patients With CRLM Using Zebra Fish Avatars-may This Model Improve Resection Rates and Survival in Patients With Upfront Non-resectable Metastatic Disease?

TypeinterventionalSponsorUniversity Hospital, LinkoepingRan2022 to 2025Enrolled40ConditionsColorectal Cancer Metastatic, Tumour Metastasis, Chemotherapy Effect, Tumor GrowthArmsChemotherapy drug
3 · Its place in the literature

Who cites it

29 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Biogenesis of Au Nanoparticles from Plant-Derived Metabolites -ACS biomaterials science & engineering · 2026
    Article
  10. Article
  11. Review
  12. Zebrafish: A Versatile and Powerful Model for Biomedical Research.BioEssays : news and reviews in molecular, cellular and developmental biology · 2025
    Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Small Fish, Big Answers: Zebrafish and the Molecular Drivers of Metastasis.International journal of molecular sciences · 2025
    Review
  18. Article
  19. Neural Basis of Number Sense in Larval Zebrafish.bioRxiv : the preprint server for biology · 2024
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Alexandra LubinResearch Department of Haematology, Cancer Institute, University College London, London WC1E 6DD, UK.ORCID 0000-0001-6592-9513
Jason OtterstromIDEA Bio-Medical Ltd., Rehovot 76705, Israel.ORCID 0000-0002-0176-9976
Yvette HoadeResearch Department of Haematology, Cancer Institute, University College London, London WC1E 6DD, UK.
Ivana BjedovResearch Department of Cancer Biology, Cancer Institute, University College London, London WC1E 6DD, UK.ORCID 0000-0001-5894-6016
Eleanor SteadResearch Department of Cancer Biology, Cancer Institute, University College London, London WC1E 6DD, UK.
Matthew WhelanDivision of Infection and Immunity, University College London, London WC1E 6BT, UK.ORCID 0000-0003-0441-3358
Gaia GestriDepartment of Cell and Developmental Biology, University College London, London WC1E 6AR, UK.ORCID 0000-0001-8854-1546
Yael ParanIDEA Bio-Medical Ltd., Rehovot 76705, Israel.ORCID 0000-0001-9544-6213
Elspeth PayneResearch Department of Haematology, Cancer Institute, University College London, London WC1E 6DD, UK.ORCID 0000-0001-5841-778X

Funding

Cancer Research UK 24873Medical Research Council MR/L003775/1Medical Research Council MR/T020164/1
6 · The paper itself

Abstract

Zebrafish provide a unique opportunity for drug screening in living animals, with the fast-developing, transparent embryos allowing for relatively high-throughput, microscopy-based screens. However, the limited availability of rapid, flexible imaging and analysis platforms has limited the use of zebrafish in drug screens. We have developed an easy-to-use, customisable automated screening procedure suitable for high-throughput phenotype-based screens of live zebrafish. We utilised the WiScan® Hermes High Content Imaging System to rapidly acquire brightfield and fluorescent images of embryos, and the WiSoft® Athena Zebrafish Application for analysis, which harnesses an Artificial Intelligence-driven algorithm to automatically detect fish in brightfield images, identify anatomical structures, partition the animal into regions and exclusively select the desired side-oriented fish. Our initial validation combined structural analysis with fluorescence images to enumerate GFP-tagged haematopoietic stem and progenitor cells in the tails of embryos, which correlated with manual counts. We further validated this system to assess the effects of genetic mutations and X-ray irradiation in high content using a wide range of assays. Further, we performed simultaneous analysis of multiple cell types using dual fluorophores in high throughput. In summary, we demonstrate a broadly applicable and rapidly customisable platform for high-content screening in zebrafish. This article has an associated First Person interview with the first author of the paper.

Indexed as

Models, AnimalAlgorithmsAnimalsDrug Evaluation, PreclinicalEmbryo, NonmammalianHigh-Throughput Screening AssaysPhenotypeZebrafishDrug screeningHigh-throughputZebrafish

Identifiers

PMID34472582
PMCPMC8430230

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.